Violation Tracker Individual Record
Company:
Cell Therapeutics Inc.
Penalty:
$10,500,000
Year:
2007
Date:
April 17, 2007
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Secondary Offense:
kickbacks and bribery
Violation Description:
Cell Therapeutics Inc. has agreed to pay the United States $10.5 million to resolve allegations of the company's improper marketing of the anti-cancer prescription drug Trisenox. According to the government's complaint, CTI promoted the drug for various uses that were unapproved by the Food & Drug Administration.
Level of Government:
federal
Action Type:
agency action
Agency:
Justice Department Civil Division
Civil or Criminal Case:
civil
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
